An open-label, single- & multiple-dose study to investigate the pharmacokinetics of sitagliptin 100 mg in healthy Chinese adult subjects
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 30 Sep 2008 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Actual patient number (16) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.